0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-71.82%PremiumJan 17, 2025Expiry Date2.09Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.59Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Kazia Therapeutics Stock Discussion
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Wednesday, 11th December at 8:00 am
SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast Cancer Symposium ...
📊⚡️📊
Larger Image: tradingview.com...
$Kazia Therapeutics (KZIA.US)$
📊⚡️📊
📊⚡️📊
No comment yet